CDC Awards $22M to Combat Antimicrobial Resistance, Infectious Diseases
The funding goes to 28 global organizations and establishes two new networks to address pathogenic threats.
Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People
Tumors in younger individuals exhibited a dysregulated molecular aging phenotype and were associated with hallmarks of premature senescence.
Breast Cancer Therapy Response Predicted by Multiomic Machine Learning Model
A team led by researchers at the University of Cambridge analyzed more than 160 pre-treatment tumor biopsies to identify features linked to treatment response.
Cytena Inks China Distribution Deal for Single-Cell Isolators
Cytena will supply nearly 100 of its single-cell isolators, including its Up Sight instrument, to China's Applitech Pharmaceutical Equipment Technology for distribution.
Less Than Half
An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.
Still Some SARS-CoV-2 Sequencing Holes
The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.
Avoiding Passing Them On
People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.
PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting
In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.
Freenome Raises $300M in Series D Financing
The company will use the funding to support commercialization of its blood-based colorectal cancer detection test and to fuel expansion to other tumor types.
More Than Dozen Genetic Loci Linked to Amyotrophic Lateral Sclerosis Risk
The risk loci highlight shared ties and differences between ALS and other neurodegenerative conditions, and further suggested a role for autophagy in ALS development.
Test of the China Initiative
According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.
Collaborative Approach
A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.
Genes of a Guide Dog
Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.
PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing
In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.
Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment
The pharma firm is using Caris’ comprehensive molecular profiling to help advance its investigational Porcupine inhibitor, RXC004, in the US.
Top Five Articles on GenomeWeb Last Week: Illumina, Qiagen, Caris Life Sciences, and More
Last week, GenomeWeb's readers were most interested in a jury's decision that BGI and its affiliates were responsible for patent infringement against Illumina.
NanoMosaic Closes $40.8M Series A Round
The firm said it will use the funds to further its commercial infrastructure and application development as it targets a Q1 2022 launch for its proteomics platform.
FDA Lists SARS-CoV-2 MDx Tests Potentially Impacted by Omicron Variant
The agency's bioinformatics analysis suggests 26 assays from 23 developers are likely to be impacted by mutations present in the Omicron variant.
In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More
News items for the week of Nov. 29, 2021.
Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis
In a cohort of almost 36,000 Icelanders, the researchers found more than 18,000 associations between sequence variants and plasma protein levels.